Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-01-05 @ 5:45 PM
Study NCT ID:
NCT04117932
Status:
COMPLETED
Last Update Posted:
2023-08-08
First Post:
2019-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
Sponsor:
CHU de Reims
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-04
First Submit QC Date:
None
Study First Post Date:
2019-10-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-07
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL